Chemical Constituents of Root Barks of Gnidia involucrata and Evaluation for Antibacterial and Antioxidant Activities.

Autor: Kalbessa A; Chemistry Department, School of Applied Natural Sciences, Adama Science and Technology University, Adama, Ethiopia., Dekebo A; Chemistry Department, School of Applied Natural Sciences, Adama Science and Technology University, Adama, Ethiopia., Tesso H; Chemistry Department, School of Applied Natural Sciences, Adama Science and Technology University, Adama, Ethiopia., Abdo T; Chemistry Department, School of Applied Natural Sciences, Adama Science and Technology University, Adama, Ethiopia., Abdissa N; Chemistry Department, College of Natural Sciences, Jimma University, Jimma, Ethiopia., Melaku Y; Chemistry Department, School of Applied Natural Sciences, Adama Science and Technology University, Adama, Ethiopia.
Jazyk: angličtina
Zdroj: Journal of tropical medicine [J Trop Med] 2019 Aug 14; Vol. 2019, pp. 8486214. Date of Electronic Publication: 2019 Aug 14 (Print Publication: 2019).
DOI: 10.1155/2019/8486214
Abstrakt: The genus Gnidia , with species close to 152, is traditionally used to treat wide ranges of ailments in humans and animals. Gnidia involucrata is one of the species found in Ethiopia and traditionally used as a laxative, antirheumatic agent, insecticide, antibacterial agent, and antimalarial agent. In view of its traditional use, the root bark was sequentially extracted with n -hexane, EtOAc, and MeOH to afford 0.78%, 4%, and 6% crude extracts, respectively. The chromatographic separation of the EtOAc extract using silica gel column chromatography yielded three pure compounds: tetratriacontanyl caffeate ( 1 ), 12- O -dodeca-2,4-dienoylphorbol-13-acetate ( 2 ), and naringenin ( 3 ). This is the first report of the isolation of 1 and its kind from the genus and most probably from the Thymelaeaceae family. The structures of these compounds were characterized and identified by NMR and mass spectrometric analyses and comparison with literature data. The EtOAc extract and isolated compounds were assessed for their in vitro antibacterial and antioxidant activities. The EtOAc extract (1.5 mg/mL) showed significant inhibitory activity against S. aureus , E. coli , P. mirabilis , and K. pneumonia bacterial strains with the highest inhibition zone observed against S. aureus (23 mm), which is even greater than that of the reference drug ciprofloxacin (22 mm). However, the inhibition displayed on these bacterial strains for the three pure compounds was marginal with variable degrees of potency between the compounds. The better activity of the crude extract could be due to the synergistic interactions of several phytochemicals present in the extract, which cannot be the case when pure compounds are evaluated alone. The antioxidant activities of the extracts and isolated compounds were evaluated using DPPH and ferric thiocyanate methods. The EtOAc and MeOH extracts and compounds 1 and 2 were found to inhibit the DPPH radical by 70.7, 66.9, 85.8, and 52.8%, respectively. The EtOAc extract and compound 1 inhibited peroxidation of lipids by 84 and 86%, respectively. The radical scavenging displayed by compound 1 was significant compared with that displayed by ascorbic acid, indicating the strong antilipid peroxidation potential of the extract of root barks of G. involucrata . Therefore, the extracts of the root bark of G. involucrata can be used as a remedy in combating diseases caused by bacteria and free radicals provided that further comprehensive evaluation could be recommended for the conclusive decision on potential candidacy of this plant.
Competing Interests: The authors declare that they have no conflicts of interest.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje